Xbaren 450 Tablet SR contains Oxcarbazepine 450 mg, an antiepileptic medication primarily used for the treatment of partial seizures in adults and children. Oxcarbazepine acts by stabilizing hyperexcited neural membranes, inhibiting repetitive neuronal firing, and reducing the propagation of seizure activity through modulation of voltage-sensitive sodium channels. The sustained-release (SR) formulation ensures a gradual release of the active ingredient, maintaining consistent plasma concentrations and improving patient compliance by reducing dosing frequency. Xbaren 450 is indicated for monotherapy or adjunctive therapy in partial seizures with or without secondary generalization. It may also be used off-label for certain mood disorders as determined by a healthcare professional. Common adverse effects include dizziness, somnolence, headache, nausea, and hyponatremia; therefore, regular monitoring of serum sodium levels is recommended during treatment. Caution is advised in patients with hepatic or renal impairment, and dose adjustments may be necessary. Xbaren 450 Tablet SR should be prescribed and administered under medical supervision, with attention to potential drug interactions, particularly with other antiepileptic drugs and oral contraceptives. Patients should be advised not to discontinue therapy abruptly due to the risk of increased seizure frequency.